"10.1371_journal.pone.0067148","plos one","2013-06-27T00:00:00Z","Sjoerd T Ligthart; Frank A W Coumans; Francois-Clement Bidard; Lieke H J Simkens; Cornelis J A Punt; Marco R de Groot; Gerhardt Attard; Johann S de Bono; Jean-Yves Pierga; Leon W M M Terstappen","Department of Medical Cell BioPhysics, MIRA Institute, University of Twente, Enschede, The Netherlands; Department of Medical Oncology, Institut Curie, Paris, France; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Department of Internal Medicine, Medisch Spectrum Twente, Enschede, The Netherlands; The Royal Marsden NHS Foundation Trust, Sutton, Surrey, United Kingdom","Conceived and designed the experiments: SL FC FCB GA LT. Performed the experiments: SL FC. Analyzed the data: SL FC FCB GA LT. Contributed reagents/materials/analysis tools: SL FC FCB LS CP MdG GA JdB JYP. Wrote the paper: SL FC FCB GA LT.","GA and JdB are employees of The Institute of Cancer Research, which has a commercial interest in the development of abiraterone acetate and GA is on The Institute of Cancer Research list of rewards to inventors of abiraterone acetate. JdB has served as a paid consultant for Johnson & Johnson and has received research support from Veridex. JYP received research grants and lecture honoraria from Veridex. FCB received lecture honoraria from Veridex. LT is a consultant for Veridex LLC. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","06","Sjoerd T Ligthart","STL",10,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
